Teva To Buy US Biotech Auspex Pharma In $3.2B Drug Merger
Israeli-based Teva Pharmaceutical Industries Ltd. said Monday it will buy California biotech Auspex Pharmaceuticals Inc. for $3.2 billion cash, bolstering its central nervous system pipeline as high-stakes deals continue to shake...To view the full article, register now.
Already a subscriber? Click here to view full article